The latest Investing Matters Podcast episode with London Stock Exchange Group's Chris Mayo has just been released. Listen here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAvi Japan Oppo. Regulatory News (AJOT)

Share Price Information for Avi Japan Oppo. (AJOT)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 130.00
Bid: 128.50
Ask: 129.50
Change: 0.50 (0.39%)
Spread: 1.00 (0.778%)
Open: 131.00
High: 131.00
Low: 128.50
Prev. Close: 129.50
AJOT Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

AVI submits shareholder proposals to NC Holdings

18 May 2023 07:00

RNS Number : 7898Z
AVI Japan Opportunity Trust PLC
18 May 2023
 

AVI Japan Opportunity Trust PLC ("AJOT" or the "Company")

LEI: 894500IJ5QQD7FPT3J73

18 May 2023

London

 

Asset Value Investors (AVI) submits shareholder proposals toNC Holdings

 

London, 18 May 2023 - Asset Value Investors ("AVI") today launched a public campaign regarding the submission of shareholder proposals to NC Holdings (TSE: 6236, "NCHD"). AVI's campaign can be found here:

www.enhancingNCHD.com

 

The conveyor belt market, in which NCHD's main business operates, is expected to shrink due to decarbonisation efforts and reduced reliance on coal-fired power generation plants. In NCHD's multi-storey parking business, competition is expected to intensify, and the business environment surrounding NCHD is extremely uncertain.

 

Under these circumstances, for shareholders and investors to understand the future potential of NCHD, it is essential to provide a clear explanation of the medium- to long-term management vision and how the company intends to increase its corporate value and protect the common interests of all shareholders. However, NCHD refuses to publish a mid-term plan.

 

In addition, NCHD's performance has been sluggish, with operating profits guidance for FY2024/3 expected to fall by almost 30% from three years ago. NCHD's management has only blamed changes in the external environment for the poor performance and has not provided a clear explanation to investors.

 

NCHD has significant net cash equivalents amounting to almost 70% of its market cap, and the need to raise funds on the stock market appears to be limited. The directors of the company are expected to weigh up various strategic alternatives, including a review of the business portfolio and capital structure, in the best interests of all shareholders. However, we do not believe that NCHD is proactively exploring all strategic alternatives, and we are concerned that the common interests of shareholders are being undermined.

 

NCHD's difficult outlook, poor performance, lack of mid-term plan and long-term vision, inefficient balance sheet, and unwillingness to explore all strategic alternatives, have led NCHD's share price to trade significantly below its intrinsic corporate value.

 

Since becoming a shareholder of NCHD in 2021, AVI, as a responsible institutional investor committed to the aims of the Stewardship Code, has privately conducted meaningful dialogue to try and enhance NCHD's medium- to long-term corporate value and, in turn, the interests of all shareholders. However, as stated above, we are unsure whether the current management and directors of the company are fully acting in the best interests of shareholders. Therefore, AVI, as a shareholder holding more than 20% of the voting rights of NCHD, has decided that it has a responsibility to act on improving the situation.

 

Considering this, AVI has submitted shareholder proposals for the best interests of all NCHD's shareholders, which are summarised as follows:

 

1. Election of Mr. Jiro Yasu and Mr. Philip Partnow, who have knowledge and experience of the capital market, as external independent directors

2. Establishment of a 'Strategic Review Committee' to evaluate the company's strategic alternatives in the best interests of all shareholders

3. Increase the annual remuneration limit of the stock compensation plan for directors to JPY 150 million with TSR and ROIC targets

4. Payment of a year-end dividend equivalent to a dividend payout ratio of 70%

 

AVI's shareholder proposals are submitted with the best interests of shareholders in mind by strengthening NCHD's supervisory function and increasing discipline over management, where the interests of shareholders have not adequately been taken into account. AVI had hoped that NCHD would have considered our proposals sincerely and engaged in proactive discussions with us. However, the Board of Directors, which has been operating without sufficient discipline, has been so averse to strengthening supervision and discipline that it has attempted to prevent our proposals from being approved. This is highlighted by the Board's opposition to AVI's shareholder proposals where they make claims that the proposals "will damage the corporate value" and "will harm the interests of shareholders," without any evidence.

 

It is regrettable that the Board of Directors has prioritised the status quo over the best interests of shareholders. As a result, NCHD's corporate governance has proven itself to be dysfunctional and in need of change. We urge all NCHD's shareholders to review the content of our shareholder proposals and the presentation material, to make an objective decision.

 

Joe Bauernfreund, CEO of AVI, stated:

 

"AVI is committed to a purposeful dialogue to benefit all shareholders of its investee companies. We have been seeking ways to bring NC Holdings' value closer to its intrinsic value through friendly and constructive dialogue in private with NC Holdings' management for two years since 2021. It is regrettable that, despite these efforts, management has not proactively listened to our recommendations, and we feel the situation is unlikely to improve. Having exhausted our attempts to keep our suggestions private, we have now, unfortunately, had to exercise our right to make shareholder proposals."

 

"We hope shareholders will see the benefit of our proposals, and if approved, that the Board of Directors will work with the Strategic Review Committee and utilise the capital markets expertise of our two proposed directors to realise the best interest of all shareholders."

 

 

***

AVI at a glance

 

AVI is an investment management company established in London, United Kingdom, in 1985, and AVI has invested in Japanese equities for more than 20 years. AVI manages AVI Global Trust (Total Gross Assets: approximately JPY190bn (£1.2bn)), AVI Japan Opportunities Trust (Total Gross Assets: approximately JPY31bn (£0.19bn)), etc., as of 31 March 2023. AGT and AJOT are public companies whose shares are listed and traded on the main market of the London Stock Exchange.

AVI has signified its commitment to the "Principles for Responsible Institutional Investors: Japan's Stewardship Code" and, in accordance with its aim, engages in constructive "purposeful dialogue" (engagement) with management and board members in order to contribute to the enhancement of the corporate value and sustainable growth of the portfolio companies.

 

Contact:

Asset Value Investors Limited

Kaz Sakai

kaz.sakai@assetvalueinvestors.com

 

Disclaimer:

In respect of content and information set out in the English language version and the Japanese language version of this press release, in the event of any inconsistency between them, the Japanese language version shall prevail unless otherwise expressly indicated.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCEAKSXFLPDEFA
Date   Source Headline
19th Oct 20229:32 amRNSMonthly update
18th Oct 202212:40 pmRNSNet Asset Value(s)
17th Oct 202211:38 amRNSNet Asset Value(s)
14th Oct 202212:50 pmRNSNet Asset Value(s)
13th Oct 202212:02 pmRNSNet Asset Value(s)
12th Oct 20221:56 pmRNSNet Asset Value(s)
11th Oct 202212:48 pmRNSNet Asset Value(s)
10th Oct 20222:39 pmRNSNet Asset Value(s)
7th Oct 202212:51 pmRNSNet Asset Value(s)
6th Oct 202211:57 amRNSNet Asset Value(s)
5th Oct 202212:01 pmRNSNet Asset Value(s)
4th Oct 202212:27 pmRNSNet Asset Value(s)
3rd Oct 20225:06 pmRNSTransaction in Own Shares
3rd Oct 20222:07 pmRNSNet Asset Value(s)
30th Sep 20221:21 pmRNSNet Asset Value(s)
29th Sep 202211:05 amRNSNet Asset Value(s)
28th Sep 202212:57 pmRNSNet Asset Value(s)
28th Sep 202210:54 amRNSInvestment Manager Increases Holding
28th Sep 20227:00 amRNSHalf-year Report
27th Sep 20223:15 pmRNSNet Asset Value(s)
26th Sep 20222:47 pmRNSNet Asset Value(s)
23rd Sep 20221:44 pmRNSNet Asset Value(s)
22nd Sep 202212:23 pmRNSNet Asset Value(s)
21st Sep 20222:04 pmRNSNet Asset Value(s)
20th Sep 20223:06 pmRNSMonthly Update
20th Sep 202212:55 pmRNSNet Asset Value(s)
16th Sep 202211:39 amRNSNet Asset Value(s)
15th Sep 202212:46 pmRNSNet Asset Value(s)
14th Sep 202212:54 pmRNSNet Asset Value(s)
13th Sep 202212:14 pmRNSNet Asset Value(s)
12th Sep 202212:40 pmRNSNet Asset Value(s)
9th Sep 20221:50 pmRNSNet Asset Value(s)
8th Sep 202212:53 pmRNSNet Asset Value(s)
7th Sep 202212:56 pmRNSNet Asset Value(s)
6th Sep 202212:41 pmRNSNet Asset Value(s)
6th Sep 20227:00 amRNSUpdate on consultation regarding Exit Opportunity
5th Sep 202212:36 pmRNSNet Asset Value(s)
2nd Sep 20222:07 pmRNSNet Asset Value(s)
1st Sep 20222:33 pmRNSNet Asset Value(s)
31st Aug 202212:34 pmRNSNet Asset Value(s)
30th Aug 20221:21 pmRNSNet Asset Value(s)
26th Aug 202212:57 pmRNSNet Asset Value(s)
26th Aug 20229:57 amRNSCompliance with Market Abuse Regulation
25th Aug 20221:22 pmRNSNet Asset Value(s)
24th Aug 20221:06 pmRNSNet Asset Value(s)
23rd Aug 20221:05 pmRNSNet Asset Value(s)
22nd Aug 20221:19 pmRNSNet Asset Value(s)
19th Aug 20221:34 pmRNSNet Asset Value(s)
18th Aug 20221:10 pmRNSNet Asset Value(s)
17th Aug 20221:45 pmRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.